Scarica l'app Stockscreener
71.75
2.12%
1.49
Dopo l'orario di chiusura:
71.74
-0.01
-0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$70.26
Aprire:
$71.56
Volume 24 ore:
10.57M
Relative Volume:
1.44
Capitalizzazione di mercato:
$91.00B
Reddito:
$386.46B
Utile/perdita netta:
$4.49B
Rapporto P/E:
20.04
EPS:
3.58
Flusso di cassa netto:
$4.78B
1 W Prestazione:
-3.16%
1M Prestazione:
+9.48%
6M Prestazione:
+8.17%
1 anno Prestazione:
+27.06%
Intervallo 1D:
$70.72
$73.05
Intervallo di 1 settimana:
$69.60
$74.49
Portata 52W:
$43.56
$74.53
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
71.75 | 89.11B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
347.92 | 290.04B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
302.01 | 80.32B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
315.09 | 69.39B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
273.02 | 37.33B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Why CVS Health (CVS) Stock Is Up Today - Yahoo Finance
CVS Health Corporation (CVS) technical analysisCVS Health (NYSE:CVS) - Benzinga
CVS Sues Takeda, Bora Units Claiming Collusion on Reflux Drug - Bloomberg Law News
Resources Management Corp CT ADV Cuts Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. (NYSE:CVS): Is there more Downside to the Stock? - MSN
Today's Moving Stocks: Planet Labs, EchoStar, Robinhood, Summit Therapeutics, BioNTech, CVS Health - Yahoo Finance
Vident Advisory LLC Trims Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
Why CVS Health (CVS) Stock Is Falling Today - Yahoo Finance
CVS Health (CVS) Shares Decline Amid Lack of New Guidance - GuruFocus
CVS Drops on Investor Worries About Government Ratings - Bloomberg.com
CVS Health Corporation $CVS Shares Acquired by Parkman Healthcare Partners LLC - MarketBeat
CVS Health Trades Cheaper Than Industry: How to Play the Stock? - Yahoo Finance
CVS Health Corporation $CVS Shares Bought by New England Asset Management Inc. - MarketBeat
House Republicans probe CVS for alleged HIPAA violation - Yahoo Finance
State of Wyoming Acquires New Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Bought by Alliancebernstein L.P. - MarketBeat
Adage Capital Partners GP L.L.C. Has $76.14 Million Position in CVS Health Corporation $CVS - MarketBeat
First Manhattan CO. LLC. Sells 13,240 Shares of CVS Health Corporation $CVS - MarketBeat
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
AQR Capital Management LLC Has $249.15 Million Position in CVS Health Corporation $CVS - MarketBeat
AlTi Global Inc. Cuts Stake in CVS Health Corporation $CVS - MarketBeat
13,153 Shares in CVS Health Corporation $CVS Purchased by National Wealth Management Group LLC - MarketBeat
Is CVS Health Stock Outperforming the Dow? - MSN
New York governor issues order to bypass Trump administration's COVID vaccine limits - Reuters
Amundi Sells 2,295,578 Shares of CVS Health Corporation $CVS - MarketBeat
Does CVS Health Corporation outperform in volatile marketsForecast Cut & AI Powered Buy and Sell Recommendations - خودرو بانک
8 Knots Management LLC Increases Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS, Walgreens To Buy Pharmacy Assets From Rite Aid Corp: Retail Sentiment Brightens - MSN
CVS (CVS) Faces Lawsuit After Dropping Eli Lilly's Drug from Cov - GuruFocus
CVS Caremark facing class action suit for dropping coverage of Lilly's Zepbound - Seeking Alpha
CVS Health (CVS): Bernstein Maintains Rating, Raises Price Targe - GuruFocus
Bernstein Raises CVS Health's PT to $77 from $72, Maintains Market Perform - AInvest
BW Gestao de Investimentos Ltda. Lowers Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Canada Pension Plan Investment Board - MarketBeat
Panagora Asset Management Inc. Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Baird Financial Group Inc. Increases Stake in CVS Health Corporation $CVS - MarketBeat
OMERS ADMINISTRATION Corp Sells 7,705 Shares of CVS Health Corporation $CVS - MarketBeat
How high can CVS Health Corporation stock goWeekly Market Outlook & Fast Exit and Entry Trade Guides - Newser
CVS Caremark’s Boosting of Wegovy Over Zepbound Fuels Lawsuits - Bloomberg Law News
Key metrics from CVS Health Corporation’s quarterly dataWeekly Trend Recap & Long-Term Safe Investment Plans - Newser
CVS Health Corporation $CVS Shares Sold by Chiron Capital Management LLC - MarketBeat
Risk adjusted return profile for CVS Health Corporation analyzedEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
Caisse DE Depot ET Placement DU Quebec Reduces Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
CVS Caremark Faces Lawsuit for Favoring Wegovy Over Zepbound (1) - Bloomberg Law News
10 Top-Performing Dividend Stocks - Morningstar
Lansforsakringar Fondforvaltning AB publ Sells 11,537 Shares of CVS Health Corporation $CVS - MarketBeat
Can CVS Health Corporation rally from current levelsPortfolio Risk Summary & Technical Pattern Alert System - Newser
63% of Americans Plan Flu Shots: CVS Health Expands with 3-in-1 Testing in 38 States for 2025-2026 - Stock Titan
Te Ahumairangi Investment Management Ltd Trims Position in CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.37%
12.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):